WHO Teams Up with Singapore Firm Tied to Pfizer and Bill Gates for Global Vaccine Passport Push

A new initiative aims to standardize cross-border health records, beginning in Southeast Asia, as critics raise questions about governance and financial ties.

By yourNEWS Media Newsroom

The World Health Organization has announced a new collaboration with Singapore-based investment firm Temasek to expand the use of digital health credential systems, building on infrastructure developed during the COVID-19 pandemic and advancing efforts to standardize health documentation across borders.

The program, described by the WHO as a rollout of interoperable digital health wallets, is designed to allow individuals to carry verified medical records, beginning with vaccination certificates and eventually expanding to broader personal health data. The initiative will first be piloted across member states of the Association of Southeast Asian Nations as part of efforts to establish a model that could be adopted internationally.

Temasek, a government-owned investment firm, previously participated in a $250 million investment in BioNTech in 2020, prior to the company’s development of a COVID-19 vaccine in partnership with Pfizer. According to a report by The Defender, the WHO said the program builds on lessons learned during the pandemic regarding the need for reliable and portable health documentation.

The effort follows amendments to the WHO’s International Health Regulations, which were updated through a set of amendments calling for globally recognized digital health certificates. Those revisions took effect in 2025 and laid the groundwork for standardized verification systems across countries.

Kee Kirk Chuen, Temasek’s head of Health & Well-being, said the pandemic demonstrated the importance of ensuring that health records are verifiable and transferable across jurisdictions.

However, some observers have raised concerns about the long-term implications of the initiative. Natalie Winters, co-host of “Bannon’s War Room,” wrote in a Substack post that systems introduced during COVID-19 as temporary measures are now being formalized into broader frameworks with extended use.

Dr. David Bell, a public health physician and senior scholar at the Brownstone Institute, said financial relationships between stakeholders and health organizations warrant scrutiny. Bell also pointed to the role of major funders such as the Gates Foundation, noting that investment interests may intersect with policy development.

Temasek’s investment history includes funding pharmaceutical and biotechnology firms involved in vaccine development and clinical research. In addition to its investment in BioNTech, the firm has supported companies such as Abogen Biosciences, which advanced mRNA vaccine candidates, and has participated in initiatives including the development of verification platforms such as Unifier for cross-border authentication of health records.

The firm has also invested in organizations connected to broader digital health ecosystems, including Clover Biopharmaceuticals, Celltrion Inc., and clinical research group Novotech. Its portfolio extends into technology platforms and financial networks involved in digital credential systems, including partnerships linked to initiatives such as the Vaccination Credential Initiative and the SMART Health Card.

Additional connections include investment relationships with firms such as BlackRock, which has held positions in major pharmaceutical companies, and involvement in programs like the Good Health Pass initiative supported by organizations affiliated with the ID2020 Alliance and the Gates Foundation.

Temasek has also collaborated with global health organizations, including Gavi, the Vaccine Alliance, which received early funding from the Gates Foundation. Joint initiatives have included immunization campaigns in Southeast Asia and partnerships with organizations such as the Clinton Health Access Initiative.

In parallel, broader digital health infrastructure efforts have expanded. In 2023, the WHO and the European Commission launched a digital health partnership, establishing the Global Digital Health Certification Network as a framework for interoperable health records. The new initiative with Temasek is expected to build on that system.

Independent journalist James Roguski previously warned in a Substack analysis that regulatory changes could lead to expanded use of global health credentials, particularly affecting international travel.

Tim Hinchliffe, editor of The Sociable, cited a World Economic Forum report describing vaccine passports as a form of digital identity, raising questions about how such systems could evolve alongside broader identity verification frameworks. He also referenced discussions around digital identity systems and their potential role in future governance structures.

The United States formally exited the WHO in January following a presidential action, after the decision was announced last year and later reported by BBC News. Prior to that withdrawal, the U.S. had been the organization’s largest contributor, followed by funding from entities including the Gates Foundation and Gavi, which the WHO lists as a stakeholder.

As the pilot program begins in Southeast Asia, the WHO and its partners are positioning the system as a framework for future global adoption, with ongoing debate surrounding governance, funding structures, and the long-term implications of standardized digital health credentials.

Original article: https://yournews.com/2026/03/31/6742980/who-teams-up-with-singapore-firm-tied-to-pfizer-and/